Concealed truth: Modeling reveals unique Quaternary distribution dynamics and refugia of four related endemic keystone <i>
![PDF) Common variants near the bradykinin receptor B 2 gene are associated with angioedema induced by angiotensin-converting-enzyme inhibitor treatment - a genome wide association study PDF) Common variants near the bradykinin receptor B 2 gene are associated with angioedema induced by angiotensin-converting-enzyme inhibitor treatment - a genome wide association study](https://i1.rgstatic.net/publication/347610213_Common_variants_near_the_bradykinin_receptor_B_2_gene_are_associated_with_angioedema_induced_by_angiotensin-converting-enzyme_inhibitor_treatment_-_a_genome_wide_association_study/links/5fe969c992851c13fec9b0b5/largepreview.png)
PDF) Common variants near the bradykinin receptor B 2 gene are associated with angioedema induced by angiotensin-converting-enzyme inhibitor treatment - a genome wide association study
![PDF) TWO SPECIES OF THE GENUS RUTSTROEMIA (RUTSTROEMIACEAE, HELOTIALES) NEW FOR MONTENEGRO: R. FRUTICETI AND R. PUNICAE SP. NOV. PDF) TWO SPECIES OF THE GENUS RUTSTROEMIA (RUTSTROEMIACEAE, HELOTIALES) NEW FOR MONTENEGRO: R. FRUTICETI AND R. PUNICAE SP. NOV.](https://i1.rgstatic.net/publication/340621884_TWO_SPECIES_OF_THE_GENUS_RUTSTROEMIA_RUTSTROEMIACEAE_HELOTIALES_NEW_FOR_MONTENEGRO_R_FRUTICETI_AND_R_PUNICAE_SP_NOV/links/5ed36de492851c9c5e6c2d8b/largepreview.png)
PDF) TWO SPECIES OF THE GENUS RUTSTROEMIA (RUTSTROEMIACEAE, HELOTIALES) NEW FOR MONTENEGRO: R. FRUTICETI AND R. PUNICAE SP. NOV.
![IJMS | Free Full-Text | Amino Acid Transporters Are a Vital Focal Point in the Control of mTORC1 Signaling and Cancer | HTML IJMS | Free Full-Text | Amino Acid Transporters Are a Vital Focal Point in the Control of mTORC1 Signaling and Cancer | HTML](https://www.mdpi.com/ijms/ijms-22-00023/article_deploy/html/images/ijms-22-00023-g004.png)
IJMS | Free Full-Text | Amino Acid Transporters Are a Vital Focal Point in the Control of mTORC1 Signaling and Cancer | HTML
![(PDF) Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph+ALL (PDF) Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph+ALL](https://i1.rgstatic.net/publication/324735074_Final_analysis_of_the_JALSG_PhALL202_study_tyrosine_kinase_inhibitor-combined_chemotherapy_for_PhALL/links/5fb7182a299bf104cf5f7590/largepreview.png)